These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18359598)

  • 1. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
    Lüdemann L; Warmuth C; Plotkin M; Förschler A; Gutberlet M; Wust P; Amthauer H
    Eur J Radiol; 2009 Jun; 70(3):465-74. PubMed ID: 18359598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
    Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
    Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
    Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
    Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
    White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
    J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study.
    Ng CS; Kodama Y; Mullani NA; Barron BJ; Wei W; Herbst RS; Abbruzzese JL; Charnsangavej C
    J Comput Assist Tomogr; 2009; 33(3):460-5. PubMed ID: 19478644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.
    Kinoshita M; Hashimoto N; Goto T; Yanagisawa T; Okita Y; Kagawa N; Kishima H; Tanaka H; Fujita N; Shimosegawa E; Hatazawa J; Yoshimine T
    Neuroimage; 2009 Apr; 45(2):312-8. PubMed ID: 19111621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of pulmonary blood flow (PBF): validation of perfusion MRI and nonlinear contrast agent (CA) dose correction with H(2)15O positron emission tomography (PET).
    Neeb D; Kunz RP; Ley S; Szábo G; Strauss LG; Kauczor HU; Kreitner KF; Schreiber LM
    Magn Reson Med; 2009 Aug; 62(2):476-87. PubMed ID: 19488992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading.
    Kim MJ; Kim HS; Kim JH; Cho KG; Kim SY
    Acta Radiol; 2008 May; 49(4):450-7. PubMed ID: 18415790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: Arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI.
    Lehmann P; Monet P; de Marco G; Saliou G; Perrin M; Stoquart-Elsankari S; Bruniau A; Vallée JN
    Eur Neurol; 2010; 64(1):21-6. PubMed ID: 20558984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
    Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
    J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.